Refractory Seizures in the Emergency Department: Diagnostic Approach and Evidence-Based Therapeutic Strategies

Read full text Summarise with VIRAT
Authors: Ciara María Murillo González, José Agustín Matamoros Bustamante, Cristian Ismael Gomez Saborío, Isis Karolina Vega Vega, Kevin Vargas Tenorio
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Refractory seizures and status epilepticus represent critical neurological emergencies associated with high morbidity and mortality in the emergency department. Their pathophysiology is driven by maladaptive neurobiological mechanisms, including disruption of inhibitory gamma-aminobutyric acid signaling, upregulation of excitatory glutamatergic receptors, impaired chloride homeostasis mediated by KCC2 dysfunction, and progressive pharmacoresistance that worsens with seizure duration. These processes provide the biological basis for current operational definitions of refractory and super-refractory status epilepticus and reinforce the principle that seizure persistence directly influences neurological outcome. Etiologically, refractory seizures arise from a heterogeneous spectrum of acute symptomatic and chronic epilepsy-related causes. Acute triggers include structural brain injury, metabolic disturbances, infections, toxic exposures, and autoimmune disorders, while chronic epilepsy-related seizures are frequently linked to suboptimal seizure control or medication non-adherence. Certain populations, such as pediatric patients, individuals with autoimmune disease, and those with new-onset refractory status epilepticus, are particularly vulnerable and pose significant diagnostic and therapeutic challenges. Management in the emergency department requires rapid stabilization, focused neurological assessment, and early identification of reversible causes. Laboratory testing, neuroimaging, and electroencephalographyespecially for detection of non-convulsive status epilepticuscare essential components of the diagnostic approach. Evidence-based treatment emphasizes timely benzodiazepine administration, followed by second-line antiepileptic drugs and escalation to anesthetic, immunomodulatory, or adjunctive therapies in refractory cases. Despite advances in pharmacological and supportive strategies, outcomes remain poor when seizure control is delayed or treatment sequences deviate from established guidelines. Coordinated multidisciplinary care and standardized clinical protocols are therefore crucial to optimize management. Ongoing research is needed to refine therapeutic pathways, improve implementation of evidence-based practices, and reduce the long-term neurological burden of refractory seizure disorders.

Fields of Study & Subjects

Epilepsy research and treatment Electroconvulsive Therapy Studies Neurological and metabolic disorders

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
28 March 2026
Language
EN